UK Edition
AdvertiseSubmit Company
PharmaJournalEvidence-Based Pharmaceutical Intelligence
RESEARCH

A universal flu vaccination might prevent a pandemic in the future.

Researchers claim to have made progress in developing a vaccine that will protect against all 20 forms of influenza. The effective Covid vaccines employ the same messenger-ribonucleic acid (mRNA) tech

16 December 20222 min readResearch
2 min read

Researchers claim to have made progress in developing a vaccine that will protect against all 20 forms of influenza.

The effective Covid vaccines employ the same messenger-ribonucleic acid (mRNA) technology.

The current yearly flu shot is updated to provide the greatest match for the strain that is currently circulating, but it is likely that it will not protect against emerging pandemic varieties.

In testing on ferrets and mice, the novel vaccination produced significant levels of antibodies that might combat a variety of diseases.

The antigens it contains can educate the immune system on how to fight them and, ideally, any new strain that could cause a pandemic, the researchers write in the journal Science. These antigens are safe copies of identifiable pieces from all 20 known subtypes of influenza A and B viruses.

According to Dr. Scott Hensley of the University of Pennsylvania, who is one of the experts working on the project, the goal of the research is to come up with a vaccination that will give people a baseline level of immunity against different flu strains.

When the next flu pandemic strikes, there will be far fewer illnesses and fatalities.

"Highly promising"
The 2009 swine flu pandemic, which was brought on by a virus that infected humans after jumping species, was not as bad as first thought.

However, it's estimated that the 1918 Spanish flu epidemic killed tens of millions of people.

Adolfo Garca-Sastre, director of the Mount Sinai Hospital's Institute for Global Health and Emerging Pathogens, stated: "Present influenza vaccinations do not protect against influenza viruses with pandemic potential.

If this vaccination is successful in people, it will do this.

Preclinical research is being done in experimental models.

"They are highly encouraging, but we cannot be sure until clinical trials in volunteers are completed," the author says, "even though they imply a protective potential against all subtypes of influenza viruses."

"All of this suggests the potential for an easily and quickly developed universal vaccine that may be of enormous assistance in the case of a pandemic breakout of a new influenza virus," said Estanislao Nistal, a virologist at San Pablo University.

Tags:PharmaceuticalPharmaceuticalpharmacypharmacypandemicpandemicmRNAmRNAribonucleic acidribonucleic acidflufluUniversity of PennsylvaniaUniversity of Pennsylvaniadrugsdrugsvaccinevaccine

Editorial Standards

This article has been reviewed by our pharmaceutical editorial team. Pharma Journal maintains strict editorial standards to ensure accuracy and reliability of all published content.

Continue Reading

Advertisement

Never Miss an Update

Stay informed with the latest pharmaceutical news, clinical research insights, and industry analysis delivered to your inbox.

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy